Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells

Combination strategies for enhancing the efficacy of immunotherapy in cancer patients

(2010) Federica Moschella et al.   Annals of the New York Academy of Sciences

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis

(2009) Daniel Hirschhorn-Cymerman et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism

(2009) G. V. Shurin et al.   JOURNAL OF IMMUNOLOGY

Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations

(2009) Ramon Kaneno et al.   Journal of Translational Medicine

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

(2008) Cédric Ménard et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

(2008) Barbara Seliger   CANCER IMMUNOLOGY IMMUNOTHERAPY

The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death

(2008) T Panaretakis et al.   CELL DEATH AND DIFFERENTIATION

Cancer Immunotherapy by Dendritic Cells

(2008) Cornelis J.M. Melief   IMMUNITY

Low-dose Chemotherapeutic Agents Regulate Small Rho GTPase Activity in Dendritic Cells

(2008) Galina V. Shurin et al.   JOURNAL OF IMMUNOTHERAPY